Are you Dr. Donnellan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 85 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
250 25th Ave N
Ste 100
Nashville, TN 37203Phone+1 615-986-7600Fax+1 615-986-7601
Summary
- Dr. William Donnellan, MD is an oncologist in Nashville, Tennessee. He is currently licensed to practice medicine in Tennessee, Georgia, and Alabama. He is affiliated with TriStar Centennial Medical Center and CHI Memorial.
Education & Training
University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014- University of Alabama Medical CenterResidency, Internal Medicine, 2008 - 2011
University of Alabama School of MedicineClass of 2008
Certifications & Licensure
GA State Medical License 2020 - 2026
TN State Medical License 2014 - 2025
AL State Medical License 2009 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias Start of enrollment: 2018 Oct 29
Publications & Presentations
PubMed
- 249 citationsIvosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemiaGail J. Roboz, Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton, Alice S. Mims
Blood. 2020-02-13 - 920 citationsDurable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AMLCourtney D. DiNardo, Eytan M. Stein, S. de Botton, Gail J. Roboz, Jessica K. Altman
The New England Journal of Medicine. 2018-06-02 - 46 citationsOlutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial.Justin M Watts, Maria R Baer, Jay Yang, Thomas Prebet, Sangmin Lee
The Lancet. Haematology. 2023-01-01
Press Mentions
Sarah Cannon to Present Latest Cancer Research Insights at 2019 American Society of Clinical Oncology’s Annual MeetingMay 30th, 2019
